Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

The market cap dived below 25M for the first time in past few months. Not a good sign.
I am really puzzled about these three things:
1) A total silence regarding Aim2Cerv program. Why does it take so long to lift the hold and get the FDA approval for the clinical trial protocol. It does look like FDA and the company have too far apart from each other to get anything done before we hear a mezzo soprano from a fat lady.
2) Why HOT is still not partnered? There is no way in hell the company can run this HOT trial alone -- no cash, no expertise.
3) NEO. I do not think they can afford to run this trial alone. Even more expensive than the other two programs, and no clear way to move forward.
I personally expect they pull a plug on AXAL and NEO soon, and keep only HOT. Which means, Petit is going to quit (or, forced to quit). Something's in the air... Smells really bad.